サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1511393

ハンチントン病治療の世界市場：規模、シェア、動向分析レポート-薬剤タイプ別、流通チャネル別、年齢別、地域別展望と予測、2024年-2031年

Global Huntington's Disease Treatment Market Size, Share & Trends Analysis Report By Drug Type (Approved Drugs (Tetrabenazine and Deutetrabenazine) and Offlabel Drugs), By Distribution Channel, By Age, By Regional Outlook and Forecast, 2024 - 2031

出版日
発行
KBV Research
ページ情報
英文 266 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.06円
ハンチントン病治療の世界市場：規模、シェア、動向分析レポート-薬剤タイプ別、流通チャネル別、年齢別、地域別展望と予測、2024年-2031年
出版日: 2024年06月28日
発行: KBV Research
ページ情報: 英文 266 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ハンチントン病治療市場規模は、予測期間中に9.0%のCAGRで市場成長し、2031年までに8億510万米ドルに達すると予想されています。

しかし、HDを引き起こすHTT遺伝子の突然変異により、有毒な変異ハンチンチンタンパク質（mHTT）が発生します。この遺伝子変異は神経機能障害を引き起こし、最終的には神経変性を引き起こします。さらに、HDの臨床症状は、症状の発現と進行の両方において個人間で大きく異なります。したがって、複雑な疾患病態生理学が市場の成長を妨げています。

パンデミックにより、ロックダウン、渡航制限、 COVID-19に対処するためのヘルスケア資源の再配分により、ハンチントン病の臨床試験の多くが中断または延期されました。さらに、パンデミックによって引き起こされた世界のサプライチェーンの混乱により、HD患者向けの医薬品や医療用品の入手可能性に影響が及びました。このように、 COVID-19パンデミックは市場に悪影響を及ぼしました。

薬剤タイプ別展望

ハンチントン病治療市場は、薬剤の種類に基づいて、承認薬と適応外薬に分けられます。2023年、適応外薬セグメントはハンチントン病治療市場で15.3％の収益シェアを獲得しました。適応外薬は、精神症状（うつ病、不安など）、易刺激性、認知障害など、ハンチントン病の特定の症状の管理に潜在的な利点をもたらす可能性があります。ヘルスケア提供者は、患者の生活の質に大きな影響を与えるこれらの困難な症状を緩和するために、適応外オプションを検討する場合があります。

流通チャネル別展望

流通チャネルに基づいて、ハンチントン病治療市場は、病院薬局、ドラッグストアおよび小売薬局、オンライン薬局に分類されます。2023年には、ドラッグストアおよび小売薬局セグメントがハンチントン病治療市場で32.7％の収益シェアを獲得しました。小売薬局では、舞踏病（不随意運動）、精神症状（うつ病、不安など）、認知障害などの治療薬を含む、ハンチントン病に関連する症状の管理に使用されるさまざまな薬を在庫しています。

年齢別展望

年齢別に見ると、ハンチントン病治療市場は50歳未満と50歳以上に分かれています。2023年には、50歳以上のセグメントがハンチントン病治療市場の収益シェアの43.3%を占めました。ハンチントン病は、高齢者では微妙な症状や非典型的な症状を呈することがあり、診断の遅れにつながります。認知度と診断能力が向上するにつれて、50歳以上のより多くの人がHDと診断され、症状に対処して生活の質を最適化するための治療と管理戦略の開始が促される可能性があります。

地域別展望

地域別に見ると、ハンチントン病治療市場は北米、欧州、アジア太平洋、ラテンアメリカ・中東・アフリカにわたって分析されています。北米地域は、2023年にハンチントン病治療市場で42％の収益シェアを記録しました。北米は他の地域よりもハンチントン病の有病率が比較的高いです。この病気は、北米で目立つ欧州系の人口の間でより一般的に診断されています。また、この地域は生物医学調査と医薬品の革新における世界的リーダーです。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場要覧

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 市場の課題
  • ポーターのファイブフォース分析

第4章 ハンチントン病治療の世界市場：薬剤タイプ別

  • 世界の承認医薬品市場：地域別
  • 世界の適応外医薬品市場：地域別

第5章 ハンチントン病治療の世界市場：流通チャネル別

  • 世界の病院薬局市場：地域別
  • 世界のドラッグストアおよび小売薬局市場：地域別
  • 世界のオンライン薬局市場：地域別

第6章 ハンチントン病治療の世界市場：年齢別

  • 世界の50歳以下の市場：地域別
  • 世界の50歳以上の市場：地域別

第7章 ハンチントン病治療の世界市場：地域別

  • 北米
    • 北米の市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米地域
  • 欧州
    • 欧州の市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州地域
  • アジア太平洋地域
    • アジア太平洋の市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカの市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ地域

第8章 企業プロファイル

  • Dr Reddy's Laboratories Ltd.
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd
  • Hikma Pharmaceuticals PLC
  • Camber Pharmaceuticals, Inc（Hetero Labs Limited）
  • Teva Pharmaceutical Industries Ltd
  • Bausch Health Companies, Inc
  • Neurocrine Biosciences Inc
  • Pfizer, Inc
  • F Hoffmann-La Roche Ltd.

第9章 ハンチントン病治療市場の成功必須条件

図表

LIST OF TABLES

  • TABLE 1 Global Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 2 Global Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 3 Global Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 4 Global Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 5 Global Approved Drugs Market by Region, 2020 - 2023, USD Thousands
  • TABLE 6 Global Approved Drugs Market by Region, 2024 - 2031, USD Thousands
  • TABLE 7 Global Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 8 Global Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 9 Global Tetrabenazine Market by Region, 2020 - 2023, USD Thousands
  • TABLE 10 Global Tetrabenazine Market by Region, 2024 - 2031, USD Thousands
  • TABLE 11 Global Deutetrabenazine Market by Region, 2020 - 2023, USD Thousands
  • TABLE 12 Global Deutetrabenazine Market by Region, 2024 - 2031, USD Thousands
  • TABLE 13 Global Offlabel Drugs Market by Region, 2020 - 2023, USD Thousands
  • TABLE 14 Global Offlabel Drugs Market by Region, 2024 - 2031, USD Thousands
  • TABLE 15 Global Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 16 Global Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 17 Global Hospital Pharmacies Market by Region, 2020 - 2023, USD Thousands
  • TABLE 18 Global Hospital Pharmacies Market by Region, 2024 - 2031, USD Thousands
  • TABLE 19 Global Drug Store & Retail Pharmacies Market by Region, 2020 - 2023, USD Thousands
  • TABLE 20 Global Drug Store & Retail Pharmacies Market by Region, 2024 - 2031, USD Thousands
  • TABLE 21 Global Online Pharmacies Market by Region, 2020 - 2023, USD Thousands
  • TABLE 22 Global Online Pharmacies Market by Region, 2024 - 2031, USD Thousands
  • TABLE 23 Global Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 24 Global Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 25 Global Below 50 years Market by Region, 2020 - 2023, USD Thousands
  • TABLE 26 Global Below 50 years Market by Region, 2024 - 2031, USD Thousands
  • TABLE 27 Global Above 50 years Market by Region, 2020 - 2023, USD Thousands
  • TABLE 28 Global Above 50 years Market by Region, 2024 - 2031, USD Thousands
  • TABLE 29 Global Huntington's Disease Treatment Market by Region, 2020 - 2023, USD Thousands
  • TABLE 30 Global Huntington's Disease Treatment Market by Region, 2024 - 2031, USD Thousands
  • TABLE 31 North America Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 32 North America Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 33 North America Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 34 North America Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 35 North America Approved Drugs Market by Region, 2020 - 2023, USD Thousands
  • TABLE 36 North America Approved Drugs Market by Region, 2024 - 2031, USD Thousands
  • TABLE 37 North America Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 38 North America Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 39 North America Tetrabenazine Market by Country, 2020 - 2023, USD Thousands
  • TABLE 40 North America Tetrabenazine Market by Country, 2024 - 2031, USD Thousands
  • TABLE 41 North America Deutetrabenazine Market by Country, 2020 - 2023, USD Thousands
  • TABLE 42 North America Deutetrabenazine Market by Country, 2024 - 2031, USD Thousands
  • TABLE 43 North America Offlabel Drugs Market by Region, 2020 - 2023, USD Thousands
  • TABLE 44 North America Offlabel Drugs Market by Region, 2024 - 2031, USD Thousands
  • TABLE 45 North America Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 46 North America Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 47 North America Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 48 North America Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 49 North America Drug Store & Retail Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 50 North America Drug Store & Retail Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 51 North America Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 52 North America Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 53 North America Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 54 North America Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 55 North America Below 50 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 56 North America Below 50 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 57 North America Above 50 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 58 North America Above 50 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 59 North America Huntington's Disease Treatment Market by Country, 2020 - 2023, USD Thousands
  • TABLE 60 North America Huntington's Disease Treatment Market by Country, 2024 - 2031, USD Thousands
  • TABLE 61 US Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 62 US Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 63 US Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 64 US Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 65 US Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 66 US Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 67 US Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 68 US Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 69 US Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 70 US Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 71 Canada Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 72 Canada Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 73 Canada Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 74 Canada Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 75 Canada Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 76 Canada Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 77 Canada Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 78 Canada Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 79 Canada Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 80 Canada Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 81 Mexico Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 82 Mexico Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 83 Mexico Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 84 Mexico Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 85 Mexico Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 86 Mexico Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 87 Mexico Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 88 Mexico Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 89 Mexico Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 90 Mexico Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 91 Rest of North America Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 92 Rest of North America Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 93 Rest of North America Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 94 Rest of North America Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 95 Rest of North America Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 96 Rest of North America Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 97 Rest of North America Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 98 Rest of North America Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 99 Rest of North America Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 100 Rest of North America Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 101 Europe Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 102 Europe Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 103 Europe Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 104 Europe Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 105 Europe Approved Drugs Market by Country, 2020 - 2023, USD Thousands
  • TABLE 106 Europe Approved Drugs Market by Country, 2024 - 2031, USD Thousands
  • TABLE 107 Europe Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 108 Europe Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 109 Europe Tetrabenazine Market by Country, 2020 - 2023, USD Thousands
  • TABLE 110 Europe Tetrabenazine Market by Country, 2024 - 2031, USD Thousands
  • TABLE 111 Europe Deutetrabenazine Market by Country, 2020 - 2023, USD Thousands
  • TABLE 112 Europe Deutetrabenazine Market by Country, 2024 - 2031, USD Thousands
  • TABLE 113 Europe Offlabel Drugs Market by Country, 2020 - 2023, USD Thousands
  • TABLE 114 Europe Offlabel Drugs Market by Country, 2024 - 2031, USD Thousands
  • TABLE 115 Europe Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 116 Europe Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 117 Europe Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 118 Europe Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 119 Europe Drug Store & Retail Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 120 Europe Drug Store & Retail Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 121 Europe Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 122 Europe Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 123 Europe Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 124 Europe Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 125 Europe Below 50 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 126 Europe Below 50 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 127 Europe Above 50 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 128 Europe Above 50 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 129 Europe Huntington's Disease Treatment Market by Country, 2020 - 2023, USD Thousands
  • TABLE 130 Europe Huntington's Disease Treatment Market by Country, 2024 - 2031, USD Thousands
  • TABLE 131 Germany Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 132 Germany Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 133 Germany Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 134 Germany Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 135 Germany Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 136 Germany Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 137 Germany Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 138 Germany Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 139 Germany Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 140 Germany Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 141 UK Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 142 UK Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 143 UK Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 144 UK Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 145 UK Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 146 UK Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 147 UK Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 148 UK Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 149 UK Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 150 UK Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 151 France Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 152 France Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 153 France Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 154 France Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 155 France Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 156 France Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 157 France Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 158 France Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 159 France Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 160 France Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 161 Russia Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 162 Russia Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 163 Russia Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 164 Russia Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 165 Russia Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 166 Russia Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 167 Russia Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 168 Russia Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 169 Russia Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 170 Russia Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 171 Spain Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 172 Spain Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 173 Spain Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 174 Spain Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 175 Spain Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 176 Spain Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 177 Spain Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 178 Spain Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 179 Spain Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 180 Spain Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 181 Italy Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 182 Italy Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 183 Italy Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 184 Italy Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 185 Italy Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 186 Italy Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 187 Italy Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 188 Italy Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 189 Italy Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 190 Italy Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 191 Rest of Europe Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 192 Rest of Europe Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 193 Rest of Europe Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 194 Rest of Europe Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 195 Rest of Europe Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 196 Rest of Europe Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 197 Rest of Europe Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 198 Rest of Europe Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 199 Rest of Europe Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 200 Rest of Europe Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 201 Asia Pacific Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 202 Asia Pacific Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 203 Asia Pacific Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 204 Asia Pacific Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 205 Asia Pacific Approved Drugs Market by Country, 2020 - 2023, USD Thousands
  • TABLE 206 Asia Pacific Approved Drugs Market by Country, 2024 - 2031, USD Thousands
  • TABLE 207 Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 208 Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 209 Asia Pacific Tetrabenazine Market by Country, 2020 - 2023, USD Thousands
  • TABLE 210 Asia Pacific Tetrabenazine Market by Country, 2024 - 2031, USD Thousands
  • TABLE 211 Asia Pacific Deutetrabenazine Market by Country, 2020 - 2023, USD Thousands
  • TABLE 212 Asia Pacific Deutetrabenazine Market by Country, 2024 - 2031, USD Thousands
  • TABLE 213 Asia Pacific Offlabel Drugs Market by Country, 2020 - 2023, USD Thousands
  • TABLE 214 Asia Pacific Offlabel Drugs Market by Country, 2024 - 2031, USD Thousands
  • TABLE 215 Asia Pacific Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 216 Asia Pacific Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 217 Asia Pacific Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 218 Asia Pacific Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 219 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 220 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 221 Asia Pacific Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 222 Asia Pacific Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 223 Asia Pacific Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 224 Asia Pacific Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 225 Asia Pacific Below 50 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 226 Asia Pacific Below 50 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 227 Asia Pacific Above 50 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 228 Asia Pacific Above 50 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 229 Asia Pacific Huntington's Disease Treatment Market by Country, 2020 - 2023, USD Thousands
  • TABLE 230 Asia Pacific Huntington's Disease Treatment Market by Country, 2024 - 2031, USD Thousands
  • TABLE 231 China Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 232 China Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 233 China Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 234 China Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 235 China Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 236 China Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 237 China Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 238 China Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 239 China Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 240 China Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 241 Japan Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 242 Japan Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 243 Japan Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 244 Japan Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 245 Japan Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 246 Japan Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 247 Japan Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 248 Japan Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 249 Japan Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 250 Japan Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 251 India Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 252 India Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 253 India Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 254 India Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 255 India Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 256 India Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 257 India Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 258 India Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 259 India Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 260 India Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 261 South Korea Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 262 South Korea Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 263 South Korea Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 264 South Korea Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 265 South Korea Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 266 South Korea Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 267 South Korea Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 268 South Korea Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 269 South Korea Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 270 South Korea Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 271 Singapore Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 272 Singapore Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 273 Singapore Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 274 Singapore Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 275 Singapore Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 276 Singapore Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 277 Singapore Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 278 Singapore Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 279 Singapore Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 280 Singapore Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 281 Malaysia Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 282 Malaysia Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 283 Malaysia Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 284 Malaysia Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 285 Malaysia Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 286 Malaysia Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 287 Malaysia Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 288 Malaysia Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 289 Malaysia Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 290 Malaysia Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 291 Rest of Asia Pacific Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 292 Rest of Asia Pacific Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 293 Rest of Asia Pacific Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 294 Rest of Asia Pacific Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 295 Rest of Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 296 Rest of Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 297 Rest of Asia Pacific Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 298 Rest of Asia Pacific Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 299 Rest of Asia Pacific Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 300 Rest of Asia Pacific Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 301 LAMEA Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 302 LAMEA Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 303 LAMEA Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 304 LAMEA Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 305 LAMEA Approved Drugs Market by Country, 2020 - 2023, USD Thousands
  • TABLE 306 LAMEA Approved Drugs Market by Country, 2024 - 2031, USD Thousands
  • TABLE 307 LAMEA Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 308 LAMEA Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 309 LAMEA Tetrabenazine Market by Country, 2020 - 2023, USD Thousands
  • TABLE 310 LAMEA Tetrabenazine Market by Country, 2024 - 2031, USD Thousands
  • TABLE 311 LAMEA Deutetrabenazine Market by Country, 2020 - 2023, USD Thousands
  • TABLE 312 LAMEA Deutetrabenazine Market by Country, 2024 - 2031, USD Thousands
  • TABLE 313 LAMEA Offlabel Drugs Market by Country, 2020 - 2023, USD Thousands
  • TABLE 314 LAMEA Offlabel Drugs Market by Country, 2024 - 2031, USD Thousands
  • TABLE 315 LAMEA Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 316 LAMEA Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 317 LAMEA Hospital Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 318 LAMEA Hospital Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 319 LAMEA Drug Store & Retail Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 320 LAMEA Drug Store & Retail Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 321 LAMEA Online Pharmacies Market by Country, 2020 - 2023, USD Thousands
  • TABLE 322 LAMEA Online Pharmacies Market by Country, 2024 - 2031, USD Thousands
  • TABLE 323 LAMEA Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 324 LAMEA Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 325 LAMEA Below 50 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 326 LAMEA Below 50 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 327 LAMEA Above 50 years Market by Country, 2020 - 2023, USD Thousands
  • TABLE 328 LAMEA Above 50 years Market by Country, 2024 - 2031, USD Thousands
  • TABLE 329 LAMEA Huntington's Disease Treatment Market by Country, 2020 - 2023, USD Thousands
  • TABLE 330 LAMEA Huntington's Disease Treatment Market by Country, 2024 - 2031, USD Thousands
  • TABLE 331 Brazil Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 332 Brazil Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 333 Brazil Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 334 Brazil Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 335 Brazil Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 336 Brazil Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 337 Brazil Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 338 Brazil Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 339 Brazil Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 340 Brazil Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 341 Argentina Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 342 Argentina Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 343 Argentina Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 344 Argentina Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 345 Argentina Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 346 Argentina Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 347 Argentina Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 348 Argentina Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 349 Argentina Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 350 Argentina Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 351 UAE Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 352 UAE Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 353 UAE Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 354 UAE Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 355 UAE Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 356 UAE Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 357 UAE Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 358 UAE Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 359 UAE Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 360 UAE Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 361 Saudi Arabia Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 362 Saudi Arabia Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 363 Saudi Arabia Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 364 Saudi Arabia Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 365 Saudi Arabia Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 366 Saudi Arabia Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 367 Saudi Arabia Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 368 Saudi Arabia Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 369 Saudi Arabia Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 370 Saudi Arabia Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 371 South Africa Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 372 South Africa Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 373 South Africa Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 374 South Africa Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 375 South Africa Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 376 South Africa Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 377 South Africa Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 378 South Africa Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 379 South Africa Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 380 South Africa Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 381 Nigeria Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 382 Nigeria Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 383 Nigeria Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 384 Nigeria Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 385 Nigeria Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 386 Nigeria Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 387 Nigeria Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 388 Nigeria Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 389 Nigeria Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 390 Nigeria Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 391 Rest of LAMEA Huntington's Disease Treatment Market, 2020 - 2023, USD Thousands
  • TABLE 392 Rest of LAMEA Huntington's Disease Treatment Market, 2024 - 2031, USD Thousands
  • TABLE 393 Rest of LAMEA Huntington's Disease Treatment Market by Drug Type, 2020 - 2023, USD Thousands
  • TABLE 394 Rest of LAMEA Huntington's Disease Treatment Market by Drug Type, 2024 - 2031, USD Thousands
  • TABLE 395 Rest of LAMEA Huntington's Disease Treatment Market by Approved Drugs Type, 2020 - 2023, USD Thousands
  • TABLE 396 Rest of LAMEA Huntington's Disease Treatment Market by Approved Drugs Type, 2024 - 2031, USD Thousands
  • TABLE 397 Rest of LAMEA Huntington's Disease Treatment Market by Distribution Channel, 2020 - 2023, USD Thousands
  • TABLE 398 Rest of LAMEA Huntington's Disease Treatment Market by Distribution Channel, 2024 - 2031, USD Thousands
  • TABLE 399 Rest of LAMEA Huntington's Disease Treatment Market by Age, 2020 - 2023, USD Thousands
  • TABLE 400 Rest of LAMEA Huntington's Disease Treatment Market by Age, 2024 - 2031, USD Thousands
  • TABLE 401 Key Information - Dr. Reddy's Laboratories Ltd.
  • TABLE 402 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 403 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 404 Key Information - Hikma Pharmaceuticals PLC
  • TABLE 405 Key Information - Camber Pharmaceuticals, Inc.
  • TABLE 406 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 407 key information - Bausch Health Companies, Inc.
  • TABLE 408 Key Information - Neurocrine Biosciences Inc.
  • TABLE 409 Key Information - Pfizer, Inc.
  • TABLE 410 Key Information - F. Hoffmann-La Roche Ltd.
目次

The Global Huntington's Disease Treatment Market size is expected to reach $805.1 million by 2031, rising at a market growth of 9.0% CAGR during the forecast period.

The Asia-Pacific region's nations are investing in expanding and modernizing its hospitals, clinics, and specialized treatment facilities. Better facilities and access to healthcare enable HD patients to receive sophisticated treatment choices, interdisciplinary care, and early diagnosis. Consequently, the Asia pacific region would acquire nearly 25% of the total market share by 2031. Genetic diversity within the Asia Pacific region provides unique opportunities for studying Huntington's Disease genetics, disease variants, and population-specific factors influencing disease progression.

Huntington's disease is caused by a mutation in the HTT gene, which produces an abnormal form of the huntingtin protein. Moreover, RNA interference (RNAi) and antisense oligonucleotides (ASOs) are biotechnological approaches that can reduce the expression of the mutant HTT gene. Moreover, RNA interference (RNAi) and antisense oligonucleotides (ASOs) are biotechnological approaches that can reduce the expression of the mutant HTT gene. Additionally, Healthcare expenditure encompasses funding allocated to biomedical research, including neurodegenerative diseases like Huntington's disease. Furthermore, investments in healthcare infrastructure, such as specialized clinics, research centers, and laboratory facilities, are essential for advancing HD research and treatment. Therefore, rising healthcare expenditures and investments are propelling the market's growth.

However, A poisonous mutant huntingtin protein (mHTT) results from an HTT gene mutation that causes HD. This genetic mutation leads to neuronal dysfunction and eventual neurodegeneration. Moreover, the clinical manifestations of HD vary widely among individuals, both in terms of symptom onset and progression. Thus, complex disease pathophysiology is hampering the growth of the market.

The pandemic led to the suspension or delay of many clinical trials for Huntington's Disease due to lockdowns, travel restrictions, and the reallocation of healthcare resources to address COVID-19. In addition, the global supply chain disruptions caused by the pandemic affected the availability of medications and medical supplies for HD patients. Thus, the COVID-19 pandemic had a negative impact on the market.

Drug Type Outlook

Based on drug type, the Huntington's disease treatment market is divided into approved drugs and offlabel drugs. In 2023, the offlable drugs segment acquired 15.3% revenue share in the Huntington's disease treatment market. Off-label drugs may offer potential benefits in managing specific symptoms of Huntington's Disease, such as psychiatric symptoms (e.g., depression, anxiety), irritability, and cognitive impairment. Healthcare providers may explore off-label options to alleviate these challenging symptoms that significantly impact patient quality of life.

Distribution Channel Outlook

On the basis of distribution channel, the Huntington's disease treatment market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. In 2023, the drug stores & retail pharmacies segment attained 32.7% revenue share in the Huntington's disease treatment market. Retail pharmacies stock a variety of medications used to manage symptoms associated with Huntington's Disease, including medications for chorea (involuntary movements), psychiatric symptoms (e.g., depression, anxiety), and cognitive impairments.

Age Outlook

By age, the Huntington's disease treatment market is bifurcated into below 50 years and above 50 years. The above 50 segment held 43.3% revenue share in the Huntington's disease treatment market in 2023. Huntington's Disease can present with subtle or atypical symptoms in older adults, leading to delays in diagnosis. As awareness and diagnostic capabilities improve, more individuals above 50 years old may receive a diagnosis of HD, prompting the initiation of treatment and management strategies to address symptoms and optimize quality of life.

Regional Outlook

Region-wise, the Huntington's disease treatment market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 42% revenue share in the Huntington's disease treatment market in 2023. North America has a relatively higher Huntington's Disease prevalence than other regions. The disease is more commonly diagnosed among populations of European descent, which are prominent in North America. Also, the region is a global leader in biomedical research and pharmaceutical innovation.

List of Key Companies Profiled

  • Bausch Health Companies, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
  • Hikma Pharmaceuticals PLC
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Neurocrine Biosciences Inc.
  • Pfizer, Inc.
  • F. Hoffmann-La Roche Ltd.

Global Huntington's Disease Treatment Market Report Segmentation

By Drug Type

  • Approved Drugs
    • Tetrabenazine
    • Deutetrabenazine
  • Offlabel Drugs

By Distribution Channel

  • Hospital Pharmacies
  • Drug Store & Retail Pharmacies
  • Online Pharmacies

By Age

  • Below 50 years
  • Above 50 years

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Huntington's Disease Treatment Market, by Drug Type
    • 1.4.2 Global Huntington's Disease Treatment Market, by Distribution Channel
    • 1.4.3 Global Huntington's Disease Treatment Market, by Age
    • 1.4.4 Global Huntington's Disease Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Global Huntington's Disease Treatment Market by Drug Type

  • 4.1 Global Approved Drugs Market by Region
  • 4.2 Global Huntington's Disease Treatment Market by Approved Drugs Type
    • 4.2.1 Global Tetrabenazine Market by Region
    • 4.2.2 Global Deutetrabenazine Market by Region
  • 4.3 Global Offlabel Drugs Market by Region

Chapter 5. Global Huntington's Disease Treatment Market by Distribution Channel

  • 5.1 Global Hospital Pharmacies Market by Region
  • 5.2 Global Drug Store & Retail Pharmacies Market by Region
  • 5.3 Global Online Pharmacies Market by Region

Chapter 6. Global Huntington's Disease Treatment Market by Age

  • 6.1 Global Below 50 years Market by Region
  • 6.2 Global Above 50 years Market by Region

Chapter 7. Global Huntington's Disease Treatment Market by Region

  • 7.1 North America Huntington's Disease Treatment Market
    • 7.1.1 North America Huntington's Disease Treatment Market by Drug Type
      • 7.1.1.1 North America Approved Drugs Market by Region
      • 7.1.1.2 North America Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.1.1.2.1 North America Tetrabenazine Market by Country
        • 7.1.1.2.2 North America Deutetrabenazine Market by Country
      • 7.1.1.3 North America Offlabel Drugs Market by Region
    • 7.1.2 North America Huntington's Disease Treatment Market by Distribution Channel
      • 7.1.2.1 North America Hospital Pharmacies Market by Country
      • 7.1.2.2 North America Drug Store & Retail Pharmacies Market by Country
      • 7.1.2.3 North America Online Pharmacies Market by Country
    • 7.1.3 North America Huntington's Disease Treatment Market by Age
      • 7.1.3.1 North America Below 50 years Market by Country
      • 7.1.3.2 North America Above 50 years Market by Country
    • 7.1.4 North America Huntington's Disease Treatment Market by Country
      • 7.1.4.1 US Huntington's Disease Treatment Market
        • 7.1.4.1.1 US Huntington's Disease Treatment Market by Drug Type
          • 7.1.4.1.1.1 US Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.1.4.1.2 US Huntington's Disease Treatment Market by Distribution Channel
        • 7.1.4.1.3 US Huntington's Disease Treatment Market by Age
      • 7.1.4.2 Canada Huntington's Disease Treatment Market
        • 7.1.4.2.1 Canada Huntington's Disease Treatment Market by Drug Type
          • 7.1.4.2.1.1 Canada Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.1.4.2.2 Canada Huntington's Disease Treatment Market by Distribution Channel
        • 7.1.4.2.3 Canada Huntington's Disease Treatment Market by Age
      • 7.1.4.3 Mexico Huntington's Disease Treatment Market
        • 7.1.4.3.1 Mexico Huntington's Disease Treatment Market by Drug Type
          • 7.1.4.3.1.1 Mexico Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.1.4.3.2 Mexico Huntington's Disease Treatment Market by Distribution Channel
        • 7.1.4.3.3 Mexico Huntington's Disease Treatment Market by Age
      • 7.1.4.4 Rest of North America Huntington's Disease Treatment Market
        • 7.1.4.4.1 Rest of North America Huntington's Disease Treatment Market by Drug Type
          • 7.1.4.4.1.1 Rest of North America Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.1.4.4.2 Rest of North America Huntington's Disease Treatment Market by Distribution Channel
        • 7.1.4.4.3 Rest of North America Huntington's Disease Treatment Market by Age
  • 7.2 Europe Huntington's Disease Treatment Market
    • 7.2.1 Europe Huntington's Disease Treatment Market by Drug Type
      • 7.2.1.1 Europe Approved Drugs Market by Country
      • 7.2.1.2 Europe Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.2.1.2.1 Europe Tetrabenazine Market by Country
        • 7.2.1.2.2 Europe Deutetrabenazine Market by Country
      • 7.2.1.3 Europe Offlabel Drugs Market by Country
    • 7.2.2 Europe Huntington's Disease Treatment Market by Distribution Channel
      • 7.2.2.1 Europe Hospital Pharmacies Market by Country
      • 7.2.2.2 Europe Drug Store & Retail Pharmacies Market by Country
      • 7.2.2.3 Europe Online Pharmacies Market by Country
    • 7.2.3 Europe Huntington's Disease Treatment Market by Age
      • 7.2.3.1 Europe Below 50 years Market by Country
      • 7.2.3.2 Europe Above 50 years Market by Country
    • 7.2.4 Europe Huntington's Disease Treatment Market by Country
      • 7.2.4.1 Germany Huntington's Disease Treatment Market
        • 7.2.4.1.1 Germany Huntington's Disease Treatment Market by Drug Type
          • 7.2.4.1.1.1 Germany Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.2.4.1.2 Germany Huntington's Disease Treatment Market by Distribution Channel
        • 7.2.4.1.3 Germany Huntington's Disease Treatment Market by Age
      • 7.2.4.2 UK Huntington's Disease Treatment Market
        • 7.2.4.2.1 UK Huntington's Disease Treatment Market by Drug Type
          • 7.2.4.2.1.1 UK Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.2.4.2.2 UK Huntington's Disease Treatment Market by Distribution Channel
        • 7.2.4.2.3 UK Huntington's Disease Treatment Market by Age
      • 7.2.4.3 France Huntington's Disease Treatment Market
        • 7.2.4.3.1 France Huntington's Disease Treatment Market by Drug Type
          • 7.2.4.3.1.1 France Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.2.4.3.2 France Huntington's Disease Treatment Market by Distribution Channel
        • 7.2.4.3.3 France Huntington's Disease Treatment Market by Age
      • 7.2.4.4 Russia Huntington's Disease Treatment Market
        • 7.2.4.4.1 Russia Huntington's Disease Treatment Market by Drug Type
          • 7.2.4.4.1.1 Russia Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.2.4.4.2 Russia Huntington's Disease Treatment Market by Distribution Channel
        • 7.2.4.4.3 Russia Huntington's Disease Treatment Market by Age
      • 7.2.4.5 Spain Huntington's Disease Treatment Market
        • 7.2.4.5.1 Spain Huntington's Disease Treatment Market by Drug Type
          • 7.2.4.5.1.1 Spain Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.2.4.5.2 Spain Huntington's Disease Treatment Market by Distribution Channel
        • 7.2.4.5.3 Spain Huntington's Disease Treatment Market by Age
      • 7.2.4.6 Italy Huntington's Disease Treatment Market
        • 7.2.4.6.1 Italy Huntington's Disease Treatment Market by Drug Type
          • 7.2.4.6.1.1 Italy Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.2.4.6.2 Italy Huntington's Disease Treatment Market by Distribution Channel
        • 7.2.4.6.3 Italy Huntington's Disease Treatment Market by Age
      • 7.2.4.7 Rest of Europe Huntington's Disease Treatment Market
        • 7.2.4.7.1 Rest of Europe Huntington's Disease Treatment Market by Drug Type
          • 7.2.4.7.1.1 Rest of Europe Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.2.4.7.2 Rest of Europe Huntington's Disease Treatment Market by Distribution Channel
        • 7.2.4.7.3 Rest of Europe Huntington's Disease Treatment Market by Age
  • 7.3 Asia Pacific Huntington's Disease Treatment Market
    • 7.3.1 Asia Pacific Huntington's Disease Treatment Market by Drug Type
      • 7.3.1.1 Asia Pacific Approved Drugs Market by Country
      • 7.3.1.2 Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.3.1.2.1 Asia Pacific Tetrabenazine Market by Country
        • 7.3.1.2.2 Asia Pacific Deutetrabenazine Market by Country
      • 7.3.1.3 Asia Pacific Offlabel Drugs Market by Country
    • 7.3.2 Asia Pacific Huntington's Disease Treatment Market by Distribution Channel
      • 7.3.2.1 Asia Pacific Hospital Pharmacies Market by Country
      • 7.3.2.2 Asia Pacific Drug Store & Retail Pharmacies Market by Country
      • 7.3.2.3 Asia Pacific Online Pharmacies Market by Country
    • 7.3.3 Asia Pacific Huntington's Disease Treatment Market by Age
      • 7.3.3.1 Asia Pacific Below 50 years Market by Country
      • 7.3.3.2 Asia Pacific Above 50 years Market by Country
    • 7.3.4 Asia Pacific Huntington's Disease Treatment Market by Country
      • 7.3.4.1 China Huntington's Disease Treatment Market
        • 7.3.4.1.1 China Huntington's Disease Treatment Market by Drug Type
          • 7.3.4.1.1.1 China Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.3.4.1.2 China Huntington's Disease Treatment Market by Distribution Channel
        • 7.3.4.1.3 China Huntington's Disease Treatment Market by Age
      • 7.3.4.2 Japan Huntington's Disease Treatment Market
        • 7.3.4.2.1 Japan Huntington's Disease Treatment Market by Drug Type
          • 7.3.4.2.1.1 Japan Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.3.4.2.2 Japan Huntington's Disease Treatment Market by Distribution Channel
        • 7.3.4.2.3 Japan Huntington's Disease Treatment Market by Age
      • 7.3.4.3 India Huntington's Disease Treatment Market
        • 7.3.4.3.1 India Huntington's Disease Treatment Market by Drug Type
          • 7.3.4.3.1.1 India Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.3.4.3.2 India Huntington's Disease Treatment Market by Distribution Channel
        • 7.3.4.3.3 India Huntington's Disease Treatment Market by Age
      • 7.3.4.4 South Korea Huntington's Disease Treatment Market
        • 7.3.4.4.1 South Korea Huntington's Disease Treatment Market by Drug Type
          • 7.3.4.4.1.1 South Korea Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.3.4.4.2 South Korea Huntington's Disease Treatment Market by Distribution Channel
        • 7.3.4.4.3 South Korea Huntington's Disease Treatment Market by Age
      • 7.3.4.5 Singapore Huntington's Disease Treatment Market
        • 7.3.4.5.1 Singapore Huntington's Disease Treatment Market by Drug Type
          • 7.3.4.5.1.1 Singapore Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.3.4.5.2 Singapore Huntington's Disease Treatment Market by Distribution Channel
        • 7.3.4.5.3 Singapore Huntington's Disease Treatment Market by Age
      • 7.3.4.6 Malaysia Huntington's Disease Treatment Market
        • 7.3.4.6.1 Malaysia Huntington's Disease Treatment Market by Drug Type
          • 7.3.4.6.1.1 Malaysia Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.3.4.6.2 Malaysia Huntington's Disease Treatment Market by Distribution Channel
        • 7.3.4.6.3 Malaysia Huntington's Disease Treatment Market by Age
      • 7.3.4.7 Rest of Asia Pacific Huntington's Disease Treatment Market
        • 7.3.4.7.1 Rest of Asia Pacific Huntington's Disease Treatment Market by Drug Type
          • 7.3.4.7.1.1 Rest of Asia Pacific Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.3.4.7.2 Rest of Asia Pacific Huntington's Disease Treatment Market by Distribution Channel
        • 7.3.4.7.3 Rest of Asia Pacific Huntington's Disease Treatment Market by Age
  • 7.4 LAMEA Huntington's Disease Treatment Market
    • 7.4.1 LAMEA Huntington's Disease Treatment Market by Drug Type
      • 7.4.1.1 LAMEA Approved Drugs Market by Country
      • 7.4.1.2 LAMEA Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.4.1.2.1 LAMEA Tetrabenazine Market by Country
        • 7.4.1.2.2 LAMEA Deutetrabenazine Market by Country
      • 7.4.1.3 LAMEA Offlabel Drugs Market by Country
    • 7.4.2 LAMEA Huntington's Disease Treatment Market by Distribution Channel
      • 7.4.2.1 LAMEA Hospital Pharmacies Market by Country
      • 7.4.2.2 LAMEA Drug Store & Retail Pharmacies Market by Country
      • 7.4.2.3 LAMEA Online Pharmacies Market by Country
    • 7.4.3 LAMEA Huntington's Disease Treatment Market by Age
      • 7.4.3.1 LAMEA Below 50 years Market by Country
      • 7.4.3.2 LAMEA Above 50 years Market by Country
    • 7.4.4 LAMEA Huntington's Disease Treatment Market by Country
      • 7.4.4.1 Brazil Huntington's Disease Treatment Market
        • 7.4.4.1.1 Brazil Huntington's Disease Treatment Market by Drug Type
          • 7.4.4.1.1.1 Brazil Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.4.4.1.2 Brazil Huntington's Disease Treatment Market by Distribution Channel
        • 7.4.4.1.3 Brazil Huntington's Disease Treatment Market by Age
      • 7.4.4.2 Argentina Huntington's Disease Treatment Market
        • 7.4.4.2.1 Argentina Huntington's Disease Treatment Market by Drug Type
          • 7.4.4.2.1.1 Argentina Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.4.4.2.2 Argentina Huntington's Disease Treatment Market by Distribution Channel
        • 7.4.4.2.3 Argentina Huntington's Disease Treatment Market by Age
      • 7.4.4.3 UAE Huntington's Disease Treatment Market
        • 7.4.4.3.1 UAE Huntington's Disease Treatment Market by Drug Type
          • 7.4.4.3.1.1 UAE Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.4.4.3.2 UAE Huntington's Disease Treatment Market by Distribution Channel
        • 7.4.4.3.3 UAE Huntington's Disease Treatment Market by Age
      • 7.4.4.4 Saudi Arabia Huntington's Disease Treatment Market
        • 7.4.4.4.1 Saudi Arabia Huntington's Disease Treatment Market by Drug Type
          • 7.4.4.4.1.1 Saudi Arabia Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.4.4.4.2 Saudi Arabia Huntington's Disease Treatment Market by Distribution Channel
        • 7.4.4.4.3 Saudi Arabia Huntington's Disease Treatment Market by Age
      • 7.4.4.5 South Africa Huntington's Disease Treatment Market
        • 7.4.4.5.1 South Africa Huntington's Disease Treatment Market by Drug Type
          • 7.4.4.5.1.1 South Africa Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.4.4.5.2 South Africa Huntington's Disease Treatment Market by Distribution Channel
        • 7.4.4.5.3 South Africa Huntington's Disease Treatment Market by Age
      • 7.4.4.6 Nigeria Huntington's Disease Treatment Market
        • 7.4.4.6.1 Nigeria Huntington's Disease Treatment Market by Drug Type
          • 7.4.4.6.1.1 Nigeria Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.4.4.6.2 Nigeria Huntington's Disease Treatment Market by Distribution Channel
        • 7.4.4.6.3 Nigeria Huntington's Disease Treatment Market by Age
      • 7.4.4.7 Rest of LAMEA Huntington's Disease Treatment Market
        • 7.4.4.7.1 Rest of LAMEA Huntington's Disease Treatment Market by Drug Type
          • 7.4.4.7.1.1 Rest of LAMEA Huntington's Disease Treatment Market by Approved Drugs Type
        • 7.4.4.7.2 Rest of LAMEA Huntington's Disease Treatment Market by Distribution Channel
        • 7.4.4.7.3 Rest of LAMEA Huntington's Disease Treatment Market by Age

Chapter 8. Company Profiles

  • 8.1 Dr. Reddy's Laboratories Ltd.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 SWOT Analysis
  • 8.2 Takeda Pharmaceutical Company Limited
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Research & Development Expense
    • 8.2.5 SWOT Analysis
  • 8.3 Sun Pharmaceutical Industries Ltd.
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 SWOT Analysis
  • 8.4 Hikma Pharmaceuticals PLC
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
  • 8.5 Camber Pharmaceuticals, Inc. (Hetero Labs Limited)
    • 8.5.1 Company Overview
  • 8.6 Teva Pharmaceutical Industries Ltd.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expenses
    • 8.6.5 SWOT Analysis
  • 8.7 Bausch Health Companies, Inc
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expense
    • 8.7.5 SWOT Analysis
  • 8.8 Neurocrine Biosciences Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Research & Development Expenses
  • 8.9 Pfizer, Inc.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Regional & Segmental Analysis
    • 8.9.4 Research & Development Expense
    • 8.9.5 SWOT Analysis
  • 8.10. F. Hoffmann-La Roche Ltd.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Segmental and Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 SWOT Analysis

Chapter 9. Winning Imperatives of Huntington's Disease Treatment Market